Factores asociados a la polifarmacia en población anciana no institucionalizada. Análisis de la submuestra de la Encuesta Nacional de Salud 2006 para personas mayores de Castilla y León

Bernal, Ernesto; Corral, Juan Carlos Martín; Galindo-Villardón, Purificación

doi:10.1016/j.regg.2011.03.002

Cited by 10 publications

(9 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The same was observed in out-patient prescriptions in 1994 in Sweden [ 18 ]. However two studies showed an association: in the non-institutionalized elderly in Castile-Leon (Spain) in 2006 [ 13 , 16 ] and only for excessive polypharmacy in 1998 in the Kuopio 75+ study (Finland) [ 12 ].…”

Section: Discussionmentioning

confidence: 99%

“…As this information is not mentioned in other studies, we looked at bad subjective health as a proxy. In the non-institutionalized older people in Castile-Leõn (Spain) in 2006, regular poor self-perceived health was associated with polypharmacy [ 13 ]. In 1997–1999, self-reported poor health correlated with increasing number of drugs taken by 70–74 year old community dwelling individuals in Western Norway [ 22 ].…”

Section: Discussionmentioning

confidence: 99%

“…In the European Health Interview Survey, which targets the population aged at least 15 and living in private households, consumption of prescribed and non-prescribed drugs in the two weeks prior to the interview is recorded (but no information is available on the type of drug). In Spain, consumption by the non-institutionalized population of prescribed and non-prescribed drugs in the two weeks prior to the interview is recorded [ 13 ].…”

Section: Discussionmentioning

confidence: 99%

“…It is consequently important to monitor excessive polypharmacy in the population and explore determinants that contribute to it. In Europe, some studies already explored this, but most of them consider only home care patients [ 4 ] or nursing home patients [ 8 , 10 ] or are limited to a specific region [ 12 , 13 ]. The present study explores within a representative sample of the general population in Belgium, the actual use of medicines in people aged sixty-five years and older, taking into account socio-demographic information, health related information and health care consumption.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Factors associated with excessive polypharmacy in older people

2015

View full text Add to dashboard Cite

BackgroundOlder people are a growing population. They live longer, but often have multiple chronic diseases. As a consequence, they are taking many different kind of medicines, while their vulnerability to pharmaceutical products is increased. The objective of this study is to describe the medicine utilization pattern in people aged 65 years and older in Belgium, and to estimate the prevalence and the determinants of excessive polypharmacy.MethodsData were used from the Belgian Health Interview Survey carried out in 2008. Each respondent was asked to show to the interviewer all medicines that he/she had taken in the 24 h prior to the interview. Excessive polypharmacy was defined as the use of nine different kind of medicines or more in the past 24 h; the relation with the Region of residence, age, gender and additional factors, such as socioeconomic status, living situation, health status and contacts with health services, was explored through multivariate models.ResultsEight percent of the older people (65 years or more) belong to the excessive polypharmacy group. Factors most strongly associated with excessive polypharmacy are: having a longstanding illness, chronic condition or handicap, at least 1 contact with a general practitioner in past 2 months and self-reported depression during the last year. Ninety percent of persons in the excessive polypharmacy group are taking medicines active on the cardiovascular system.ConclusionsIn order to optimize the use of medicines, it is necessary to find a balance between adequate treatment of diseases and avoiding adverse effects of medicines. Interventions should aim to increase awareness among healthcare professionals and patients; they should focus on general practitioners and patients with cardiovascular diseases, those suffering from depression and those aged 80 years and over. Monitoring excessive polypharmacy in the older population remains important. Further studies should explore more in depth other and more specific determinants of excessive polypharmacy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Factors associated with excessive polypharmacy in older people

2015

View full text Add to dashboard Cite

show abstract

“…The result is consistent with a previous study of hypertensive patients in which comorbid conditions negatively affected HRQOL (Aydemir, Ozdemir, & Koroglu, 2005). Elderly with multiple comorbid conditions have to deal with polypharmacy (Frutos Bernal, Martín Corral, & Galindo Villardón, 2011). In addition, a sense of burden with regard to the daily management and treatment of multiple chronic conditions, worries about increased health care costs or adverse drug reactions, and challenges regarding medication adherence have been reported in elderly patients with comorbidity (Elliott, 2009; Hsu et al, 2010).…”

Section: Discussionmentioning

confidence: 99%

Correlates of Health-Related Quality of Life Among Korean Immigrant Elders

2013

View full text Add to dashboard Cite

Health-related quality of life (HRQOL) is a key clinical outcome, particularly for individuals with chronic conditions such as hypertension (HTN). While no previous research has examined contributors to HRQOL among Asian Americans in the United States, this study was conducted to identify correlates of HRQOL in hypertensive Korean immigrant elders (≥ 60 years of age) to address the gap. A total of 440 Korean elders with HTN participated in the study. The hierarchical regression model for HRQOL explained 32.8% of the variance. Female gender (β = .109, p = .036), a greater number of comorbid conditions (β = .183, p = .000), lower social support (β = −.240, p = .000), and greater depressive symptoms (β = .402, p = .000) were associated with poorer HRQOL. Depression was the most potent correlate of HRQOL among elderly Korean Americans (KA) with HTN. Future intervention should consider managing depression as an essential component of comprehensive HTN care for this minority population.

show abstract